This PDF file includes:  fig. S1. Percentages of double-positive IL-17 + IFN- + and IL-17 + IL-22 + T cells in the intestinal mucosa of HCs and RRMS patients with active disease (RRMS/EDA) or inactive disease (RRMS/NEDA).  fig. S2. Percentages of intestinal TH cell subsets in RRMS patients stratified according to immunomodulatory treatment.  fig. S3. Correlative statistical analysis between percentages of intestinal TH17 cells and age, EDSS score, and disease duration.  fig. S4. Characterization of Streptococcus species by amplification and sequencing.  fig. S5. Correlative analysis of relative abundance of Prevotella and Streptococcus strains in mucosa-associated microbiota and age, EDSS score, and disease duration.  fig. S6. Relative abundance of Prevotella and Streptococcus strains in HCs and RRMS patients stratified according to immunomodulatory treatment. fig. S1. Percentages of double-positive IL-17 + IFN- + and IL-17 + IL-22 + T cells in the intestinal mucosa of HCs and RRMS patients with active disease (RRMS/EDA) or inactive disease (RRMS/NEDA). Single cell suspensions isolated from small intestinal tissues were stained with monoclonal Abs against CD3 and CD4 and for intracellular cytokines with anti-IL-17A, anti-IFN- and anti-IL-22 mAbs and FACS analyzed. Frequencies of double positive IL-17 + IFN- + and IL-17 + IL-22 + T cells among total CD3 + CD4 + T cells are presented. *P< 0.05 by unpaired t-test.
fig. S2. Percentages of intestinal TH cell subsets in RRMS patients stratified according to immunomodulatory treatment.
At the time of EGD and intestinal tissue sampling all RRMS patients enrolled in this study were undergoing treatment with immune modulatory drugs as Beta-interferon (type 1 interferon beta-T1IFN-b), Glatiramer Acetate (GA) and Fingolimod. Percentages of intestinal TH17, TH1 and TH22 cells out of total CD4 + T cells in the three cohorts of RRMS patients and healthy controls (HC) are shown. *P< 0.05 by unpaired t-test.
fig. S3. Correlative statistical analysis between percentages of intestinal TH17
cells and age, EDSS score, and disease duration. Linear regression analysis showed no correlation between age (years) and intestinal TH17 cell percentages in HC and RRMS patients (r=0.006) . The percentages of intestinal TH17 cells did not correlate also with the disability (EDSS score) and disease duration at the time of intestinal immunological profiling (EGD and sample collection) in RRMS patients (r=-0.04 for EDSS and r=-0.003 for disease duration). 
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